# Albemarle (ALB) — Earnings

ALB · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/alb/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $3.75 |
| EPS estimate | $3.20 |
| EPS surprise | +17.09% |
| Revenue surprise | +8.49% |
| Revenue | $1.7B |
| Revenue estimate | $1.6B |
| Reported | Aug 5, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/915913/000091591326000102/alb-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/0942899c-90bb-c7e8-8cb9-7c4324e2c02f.html) |

Albemarle reported Q2 2026 results on August 5, 2026. Earnings per share came in at $3.75, ahead of the $3.20 estimate by 17.09%. Revenue was $1.7 billion, above the $1.6 billion consensus by about 8.5%. Compared with Q2 2025, EPS rose from just $0.11, and revenue rose about 31% from $1.3 billion. Q1 2026 had beaten its estimate by 147.03%.

Annual EPS was $21.95 in 2022 and $22.24 in 2023, with a peak of $10.32 per share in Q1 2023. Albemarle then posted a loss of $2.34 per share for 2024 and a loss of $0.79 for 2025, with losses in five of those eight quarters. The deepest was $1.55 in Q3 2024. Quarterly revenue fell from $2.6 billion in early 2023 to $1.1–1.4 billion in 2024 and 2025. The first half of 2026 adds up to $6.70 per share, against a combined loss of $0.07 a year earlier. Over the last 20 quarters, Albemarle beat the EPS estimate 15 times.

Albemarle reported Q3 between November 1 and November 6 in each of the past five years. That points to early November 2026 for the next report, which will show whether the return to profit seen in 2026 holds.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 5, 2026 | $3.20 | $3.75 | 17.09% | $1.6B | $1.7B |
| Q1 2026 | May 6, 2026 | $1.19 | $2.95 | 147.03% | $1.3B | $1.4B |
| Q4 2025 | Feb 11, 2026 | −$0.42 | −$0.53 | -26.85% | $1.3B | $1.4B |
| Q3 2025 | Nov 5, 2025 | −$0.86 | −$0.19 | 77.95% | $1.3B | $1.3B |
| Q2 2025 | Jul 30, 2025 | −$0.84 | $0.11 | 113.14% | $1.2B | $1.3B |
| Q1 2025 | Apr 30, 2025 | −$0.66 | −$0.18 | 72.75% | $1.2B | $1.1B |
| Q4 2024 | Feb 12, 2025 | −$0.69 | −$1.09 | -57.99% | $1.3B | $1.2B |
| Q3 2024 | Nov 6, 2024 | −$0.44 | −$1.55 | -253.24% | $1.4B | $1.4B |
| Q2 2024 | Jul 31, 2024 | $0.43 | $0.04 | -90.63% | $1.3B | $1.4B |
| Q1 2024 | May 1, 2024 | $0.25 | $0.26 | 2.89% | $1.3B | $1.4B |
| Q4 2023 | Feb 14, 2024 | $0.98 | $1.85 | 88.08% | $2.2B | $2.4B |
| Q3 2023 | Nov 1, 2023 | $3.75 | $2.74 | -26.99% | $2.5B | $2.3B |
| Q2 2023 | Aug 2, 2023 | $4.48 | $7.33 | 63.59% | $2.4B | $2.4B |
| Q1 2023 | May 3, 2023 | $7.27 | $10.32 | 41.99% | $2.7B | $2.6B |
| Q4 2022 | Feb 15, 2023 | $8.26 | $8.62 | 4.35% | $2.6B | $2.6B |
| Q3 2022 | Nov 2, 2022 | $6.97 | $7.50 | 7.59% | $2.2B | $2.1B |
| Q2 2022 | Aug 3, 2022 | $3.11 | $3.45 | 10.95% | $1.4B | $1.5B |
| Q1 2022 | May 4, 2022 | $1.64 | $2.38 | 45.34% | $1.0B | $1.1B |
| Q4 2021 | Feb 16, 2022 | $1.00 | $1.01 | 1.35% | $897.3M | $894.2M |
| Q3 2021 | Nov 3, 2021 | $0.77 | $1.05 | 36.88% | $765.1M | $830.6M |

## Frequently Asked Questions

### When did Albemarle (ALB) last report earnings?

Albemarle last reported on Aug 5, 2026, covering fiscal Q2 2026.

### Did ALB beat earnings estimates?

Yes. Albemarle reported EPS of $3.75 for Q2 2026 against a $3.20 estimate — a 17.09% beat.

### How much revenue did ALB report last quarter?

Albemarle reported $1.7B in revenue for Q2 2026, against a consensus estimate of $1.6B.

## Similar Stocks

- [CBT](https://www.lighthorse.io/tickers/cbt) — Cabot Corporation Common Stock
- [NTR](https://www.lighthorse.io/tickers/ntr) — Nutrien Ltd. Common Shares
- [CMC](https://www.lighthorse.io/tickers/cmc) — Commercial Metals Company Common Stock
- [ASIX](https://www.lighthorse.io/tickers/asix) — AdvanSix Inc. Common Stock
- [CC](https://www.lighthorse.io/tickers/cc) — Chemours Company (The) Common Stock
- [FMC](https://www.lighthorse.io/tickers/fmc) — FMC Corporation Common Stock
- [TSLA](https://www.lighthorse.io/tickers/tsla) — Tesla, Inc.  - Common Stock
- [KOP](https://www.lighthorse.io/tickers/kop) — Koppers Holdings Inc. Common Stock
- [CE](https://www.lighthorse.io/tickers/ce) — Celanese Corporation Common Stock
- [LAC](https://www.lighthorse.io/tickers/lac) — Lithium Americas Corp. Common Shares

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).